Good News for Specialty Practices – PARx Solutions Expands Partnership with ZappRx

By Dan Rubin, CEO

Recently, PARx expanded our partnership with ZappRx, a healthcare technology company that reduces the administrative burden associated with prescribing specialty medications. As of June 2018, ZappRx users  – which range from large academic medical centers to small, independent physician practices – can access PARx Solutions’ prescription prior authorization services across all treatment areas supported on the ZappRx platform. This is especially good news for practices in Gastroenterology, Rheumatology, Cardiology, and Neurology, broadening their ability to significantly shorten the prior authorization timeline. ZappRx leverages our PASS (prior authorization support system) to alleviate the administrative burden for medical practices.

As I noted in the announcement of this expanded partnership, since the beginning, ZappRx and PARx Solutions have been very complementary. We believe that ZappRx offers specialty drug prescribers a comprehensive solution that makes it dramatically easier for physicians to combat and treat complex diseases. Together, we have been tremendously successful in the past 18 months within the Pulmonary Arterial Hypertension (PAH), Idiopathic Pulmonary Fibrosis, and Cystic Fibrosis (CF) therapeutic categories, adding support this year for Congestive Heart Failure and Hyperlipidemia. We are excited to extend our joint solutions into new therapeutic categories, which will immediately and dramatically increase the number of lives we can positively impact.

And it’s already working: according to a ZappRx’s pre-implementation survey results, physicians who prescribed specialty drugs experienced PA approval rates below 75 percent before using the integrated ZappRx -PARx approach, In contrast, the ZappRx-PARx solution has produced approval rates of 95 percent, with approvals secured in a matter of days, not weeks, even for complex conditions such as PAH.

At a recent launch of the ZappRx Platform at a prestigious academic medical center, prescribers were thrilled to have the first PA submitted through the Platform approved the same afternoon.  ‘The clinical staff was so surprised at the quick turnaround, that they actually reached out to our team to see if we were playing a joke,’ said Karen Tirozzi, Vice President of Solutions at ZappRx.  PARx is excited about continuing to expand our partnership with ZappRx and look forward to providing PA support services to new health care organizations and physicians who choose the ZappRx platform for their specialty drug prescribing support.

Generating High PA Approval Rates: Important But Not Sufficient

Pharmaceutical Executive | Dan Rubin | March 28, 2018

pharmacy-pa-problemsFor many pharmaceutical brands, managed care restrictions put tremendous pressure on the ability for patients to access prescribed medications, even when their physicians deem a particular medication to be best suited to treat their condition. To combat this challenge, many brands have engaged third parties to implement programs designed to assist physician practices with managing the cumbersome prior authorization (PA) process. While these programs may help generate higher PA approval rates, this metric alone is insufficient in evaluating whether the program is truly beneficial to patients and impactful for the sponsoring brand.  Read the full article

Reflecting on 2017, Looking Ahead to 2018

By Dan Rubin, CEO

Happy New Year to everyone!  As people often do, when a year ends, I like to reflect upon the accomplishments of the past year while looking forward to the great things ahead in the coming year.

2017 was a banner year at PARx Solutions.  The company continued to grow in both prior authorization (PA) volume and clients.  PARx assisted more physician practices with their PA support than in any previous year.  We added new capabilities in our PARx Prior Authorization Support System (PASS) system and launched new services to better support patients, physician practices and our pharmaceutical clients.

Why are more and more pharmaceutical clients and physician practices choosing PARx as their partner to assist with PA management and support?  From a pharma perspective, we have seen more brands abandon their previous “forms based” PA service as they realize that simply sending a PA form to a physician does not ensure that the PA will be submitted.  Several clients commented that they were no longer interested in paying for PAs that are never submitted to plans.

Physician practices are learning that the PA process often doesn’t end when the initial form is submitted to the plan.  Many plans send back second patient-specific forms to be completed.  Follow-up calls to plans to check status often result in long telephone hold times.  In general, practices have come to appreciate the full-service approach to PA management offered by PARx.

PARx launched several new enhancements to our PASS system in 2017.  Early in the year, we introduced our group practice log-in credentials, enabling a designated registrant from a group practice to submit PAs for any physician in the practice under a single user log-in.  At the same time, we simplified our registration process, allowing new users to register and electronically sign their HIPAA business associate agreement at the same time.  In the summer, PARx launched Guest PASS, enabling any physician to submit PAs through PARx Solutions, whether they were registered on not.  We also added a “Chart Upload” feature that makes it much easier to include supportive information from the patient’s medical record.

In 2017, PARx offered our new “PA Card” service.  This new service works in partnership with coupon card providers to identify new Rx’s filled with the assistance of a coupon card but where the primary insurance requires a PA.  In these cases, PARx notifies the prescribing physician that their patient will require a PA in order to get their refills covered by their plan, and provides a unique code where the physician (whether registered or not) can access a partially completed PA for that patient in PASS.

With 2017 in the rearview mirror, we are excited about what is in store for PARx in 2018.  We expect to continue to add new capabilities and services to support our physician practices and pharma clients.  By mid-year, PARx will introduce our new electronic PA (ePA) capability.  The PARx ePA service will be a unique “hybrid” service offering both speed and convenience for PA submissions to plans that are “ePA ready,” while continuing to provide our high level of full-service support for submissions to plans that are not yet equipped to handle ePAs.  This whole process will be “invisible” to physician practices as they will simply access all their PAs through our PASS portal as they have done in the past.  We are confident that our approach to ePA will set a high standard for PA support in the industry.

As always, I want to thank all of our physicians, their staff, and our pharmaceutical clients for their support and I look forward to working together in 2018 and beyond.

Meeting the Prior Authorization Challenge Podcast Series – Staff Productivity

By Dan Rubin, CEO

Now on our podcast page – the second installment of the “Meeting the Prior Authorization Challenge” podcast series! The newest episodes of this free resource cover maximizing optimal staff productivity in the face of a changing prior authorization landscape. PARx Director of Operations and Training Rabia Kabeer is joined by a Nurse Practitioner and a Practice Manager to deliver valuable insights into how PA’s have evolved, the pain points associated with them and how to give your staff the tools to make the most of their already busy schedules.

Topics addressed in this podcast series are:

Episode Four: How is the prior authorization landscape changing?
PARx’s own Director of Operations and Training Rabia Kabeer kicks off the staff productivity discussion by explaining how prior authorizations have changed over the last decade. She also provides an overview of our recent innovation, GUEST PASS, which allows any provider to submit a prior authorization using the PARx Prior Authorization Support System (‘PASS’), without going through the registration process.

Episode Five: Saving time with prior authorizations
Nurse Practitioner Jennifer Gillis weighs in on increasing prior authorization requirements and how the fluid, easy-to-use PASS system has cut the time needed to process them by 20% for her practice.

Episode Six: How PASS improves practice workflow
Practice Manager Kathy Parish explains how prior authorizations previously were complex and hard to keep track of.  Now her practice uses the PARx Solutions platform PASS, streamlining and speeding up the process.

Take a listen, and let us know what you think! Have a topic you’d like addressed in a future podcast? Drop a line to ariane@warnerpr.com with your suggestion and feedback.

Episode Four: How is the prior authorization landscape changing?

PARx’s own Director of Operations and Training Rabia Kabeer kicks off the staff productivity discussion by explaining how prior authorizations have changed over the last decade.

Kabeer also provides an overview of our recent innovation, GUEST PASS, which allows any provider to submit a prior authorization using the PARx Prior Authorization Support System (‘PASS’), without going through the registration process.

Note: This audio player is not supported in Internet Explorer 8 and earlier versions.

Episode Five: Saving time with prior authorizations

Nurse Practitioner Jennifer Gillis weighs in on increasing prior authorization requirements and how the fluid, easy-to-use PASS system has cut the time needed to process them by 20% for her practice.

Note: This audio player is not supported in Internet Explorer 8 and earlier versions.

Episode Six: How PASS improves practice workflow

Practice Manager Kathy Parish explains how prior authorizations previously were complex and hard to keep track of. Now her practice uses the PARx Solutions platform PASS, streamlining and speeding up the process.

Note: This audio player is not supported in Internet Explorer 8 and earlier versions.